Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 20.95 22.98
State Ba 186.10 9.31
Tata Mot 105.15 8.96
Axis Ban 418.00 1.98
Indusind 510.85 17.48
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
Sector Watch
Economy Watch
Mavens Biotech Limited
Sector:Others Others - Miscella - Others
Market Lot: 1Face Value: 1ISIN Demat: INE856C01047
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

The company announced fall of 52.66% in standalone net profit on y-o-y basis to Rs 0.89 million, while total income rose 2.20% y-o-y basis to Rs 116.10 million for the quarter ended March 2013.

Recent Developments
Mavens Biotech, a plant biotechnology company today entered into seed production Business Profile from last rabi season/year. This is a pilot project in the seeds sector and will enable the company to set up a quality seed production center with best practices and cater to the growing needs of the farmers for quality panting material.

Mavens Biotech, engaged in the business of tissue culture plants and bio informatics, has today signed an MoU with Bangalore based Garuda Group to jointly develop projects in real estate, township development and other infrastructure related areas

Mavens Biotech is a plant biotechnology company with two key business areas Bioinformatics Plant Tissue Culture Unit. It lost a total of 23.35% during last 5 weeks. Its share price as on July 15, 2010 stood at Rs 50.89.

Aarey Drugs & Pharmaceuticals manufactures active pharmaceutical ingredients/bulk drugs and offers a range of products for diverse industrial applications, it lost total of 35.65% during last 5 weeks. Its share price as on Feb. 18, 2010 stood at Rs 34.3.

In tissue culture segment, it has drawn a phase wise plan to increase its tissue culture capacity in India to 50 million plants.

In Brief

Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited